National HealthCare Corporation
Income Statement
| Line Item | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $300.7M | $297.2M | $300.9M | $288.5M | $282.6M | $269.6M | $264.6M | $270.8M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $7.2M | $6.2M | $21.41T | $5.7M | $5.0M | $5.7M | $4.0M | $6.1M |
| Operating Income | $22.5M | $15.7M | $20.4M | $13.0M | $14.0M | $10.0M | $9.1M | $4.1M |
| Operating Margin | 7.5% | 5.3% | 6.8% | 4.5% | 4.9% | 3.7% | 3.4% | 1.5% |
| Interest Expense | $0 | $46.0K | $56.0K | $77.0K | $93.0K | $98.0K | $112.0K | $137.0K |
| Pretax Income | $36.6M | $35.7M | — | $14.0M | — | — | — | — |
| Income Tax Expense | $9.5M | $9.5M | $8.7M | $3.9M | $6.4M | $4.4M | $1.8M | $-1.1M |
| Net Income | $26.8M | $26.2M | $28.4M | $10.4M | $16.3M | $11.7M | $6.4M | $-2.4M |
| Net Margin | 8.9% | 8.8% | 9.4% | 3.6% | 5.8% | 4.3% | 2.4% | -0.9% |
| EPS (Basic) | $1.74 | $1.71 | $1.86 | $0.68 | $1.06 | $0.76 | $0.42 | $-0.16 |
| EPS (Diluted) | $1.73 | $1.69 | $1.84 | $0.68 | $1.06 | $0.76 | $0.41 | $-0.16 |
| Shares Outstanding (Basic) | 15.4M | 15.4M | 15.3M | 15.3M | 15.3M | 15.3M | 15.4M | 15.4M |
| Shares Outstanding (Diluted) | 15.6M | 15.5M | 15.4M | 15.3M | 15.3M | 15.4M | 15.4M | 15.4M |
| Dividends Per Share | $0.61 | $0.59 | $0.59 | $0.59 | $0.59 | $0.57 | $0.57 | $0.57 |